Advertisements


Sonoma Pharmaceuticals Reports Third Quarter FY 2020 Financial Results

PETALUMA, Calif., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Quarterly Net Loss Reduced by 53% Compared to Prior Year YTD Net Loss Reduced by 82% Compared to Prior Year Total YTD Revenues of $14.4 Million Lower by 2% Compared to Prior Year S.....»»

Category: earningsSource: benzingaFeb 14th, 2020

Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

EXTON, Pa., April 30, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. ("Idera" or the "Company") (NASDAQ:IDRA) today reported its.....»»

Category: earningsSource: benzingaApr 30th, 2020

LEXICON PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

THE WOODLANDS, Texas, April 27, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), to.....»»

Category: earningsSource: benzingaApr 27th, 2020

Salarius Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results

Seclidemstat Achieves Dose-Escalation Milestone in Phase 1/2 Ewing Sarcoma Clinical Trial Sixth Level Dosing Cohort Now Proceeding; On Track To Report Topline Data in 2020 HOUSTON, March 23, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc.....»»

Category: earningsSource: benzingaMar 23rd, 2020

Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

Completed enrollment for the pivotal REST-ON Phase 3 study in Q4 2019; data readout expected in Q2 2020 Raised $65 million in gross proceeds from privat.....»»

Category: earningsSource: benzingaMar 12th, 2020

LEXICON PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

XERMELO® (telotristat ethyl) 2019 U.S. Net Sales Reached $31.0 Million THE WOODLANDS, Texas, March 12, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), today reported financial results for the three .....»»

Category: earningsSource: benzingaMar 12th, 2020

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

SAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), a clinical stage pharmaceutical company focused on the discovery, development a.....»»

Category: earningsSource: benzingaMar 9th, 2020

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

-- On track to complete rolling NDA submission to the FDA for setmelanotide in POMC and LEPR deficiency obesities in the first quarter of 2020 -- -- Granted orphan dru.....»»

Category: earningsSource: benzingaMar 2nd, 2020

Arena Announces Management and Program Updates and Reports Fourth Quarter and Full-Year 2019 Financial Results

SAN DIEGO, Feb. 26, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) today provided a corporate update and reported financial results for th.....»»

Category: earningsSource: benzingaFeb 26th, 2020

Spring Bank Pharmaceuticals Reports 2019 Fourth Quarter and Full-Year Financial Results

HOPKINTON, Mass., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Spring .....»»

Category: earningsSource: benzingaFeb 14th, 2020

InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update.....»»

Category: earningsSource: benzingaFeb 14th, 2020

Medexus Pharmaceuticals Reports Operating and Financial Results for the Second Quarter of Fiscal 2020

Q2 2019 Metojectâ„¢ unit market demand increased 115%1;Rasuvoâ„¢ unit market demand increased 15%2; andRupallâ„¢ unit market demand increased 66%3 Medexus management to host conference call at 8:00 AM ET on Monday, December 2, 2019 TORONTO.....»»

Category: earningsSource: benzingaNov 29th, 2019

Tonix Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights

50% of Enrollment Complete for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD Results from RECOVERY Interim Analysis Expected First Quarter 2020 Topline Data Expected Second Quarter 2020 Based on Cu.....»»

Category: earningsSource: benzingaNov 8th, 2019

Medexus Pharmaceuticals Reports Operating and Financial Results for the First Quarter of Fiscal 2020

Record Revenue of $16.1 Million $0.5 million of .....»»

Category: earningsSource: benzingaAug 22nd, 2019

Tonix Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights

Enrollment Continues for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD; Topline Data Expected First Half of 2020 Pipeline Expanded in Addiction Medicine with Cocaine .....»»

Category: earningsSource: benzingaAug 12th, 2019

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2019 Financial Results

Strong Annual Year-Over-Year Growth with 14% Revenue Growth Strong Quarter-Over-Quarter Growth with 20% Reve.....»»

Category: earningsSource: benzingaJul 8th, 2019

Intel reports 3Q20 financial results

Intel has reported third-quarter 2020 financial results, generating US$8.2 billion in cash from operations and paying dividends of US$1.4 billion......»»

Category: topSource: digitimesOct 23rd, 2020

The Valens Company Reports Financial Results for the Third Quarter of Fiscal 2020

KELOWNA, BC, Oct. 14, 2020 /PRNewswire/ - The Valens Company Inc.  (TSX:VLNS) (OTCQX:VLNCF) (the "Company," "The Valens Co.....»»

Category: earningsSource: benzingaOct 14th, 2020

The Valens Company Reports Financial Results for the Third Quarter of Fiscal 2020

KELOWNA, BC, Oct. 14, 2020 /CNW/ - The Valens Company Inc.  (TSX:VLNS) (OTCQX:VLNCF) (the "Company," "The Valens Company" or "Valens"), a global leader in the end-to-end de.....»»

Category: earningsSource: benzingaOct 14th, 2020

VOXX International Corporation Reports Its Fiscal 2021 Second Quarter Financial Results

ORLANDO, Fla., Oct. 13, 2020 /PRNewswire/ -- VOXX International Corporation (NASDAQ:VOXX), a leading manufacturer and distributor of automo.....»»

Category: earningsSource: benzingaOct 13th, 2020

Enzo Biochem Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Company reports $19.5 million in revenue and EPS of ($0.07) in the fourth quarter with significant margin expansion s.....»»

Category: earningsSource: benzingaOct 13th, 2020